Accuracy of Different Bioinformatics Methods in Detecting Antibiotic Resistance and Virulence Factors from Staphylococcus aureus Whole-Genome Sequences. by Mason, Amy et al.
1 
Accuracy of different bioinformatics methods in detecting antibiotic resistance 1 
and virulence factors from Staphylococcus aureus whole genome sequences.  2 
 3 
Authors: Amy Mason*1, Dona Foster*1#, Phelim Bradley*2, Tanya Golubchik*1, Michel 4 
Doumith*3, N. Claire Gordon1, Bruno Pichon3, Zamin Iqbal2, Peter Staves3, Derrick 5 
Crook1,4,5,6, A. Sarah Walker**1,5,6, Angela Kearns**3,5, Tim Peto**1,5,6  6 
*/** contribution considered equal 7 
 8 
1 Nuffield Department of Medicine, University of Oxford, UK 9 
2 Wellcome Trust Centre for Human Genetics, University of Oxford, UK 10 
3 Staphylococcus Reference Service, National Infection Service, Public Health England, 11 
UK 12 
4 National Infection Service, Public Health England, UK 13 
5 The National Institute for Health Research (NIHR) Health Protection Research Unit in 14 
Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford, 15 
UK 16 
6 NIHR Oxford Biomedical Research Centre, University of Oxford, UK 17 
 18 
Running Head: S. aureus Whole-genome Sequence Method Comparison 19 
 20 
#Address correspondence to Dr Dona Foster, Microbiology Level 7, John Radcliffe 21 
Hospital, Headley Way, Oxford, OX3 9DU. dona.foster@ndm.ox.ac.uk 22 
Current institution: Amy Mason: Department of Mathematics and Department of 23 
Statistics, University of Oxford, UK. N. Claire Gordon: KEMRI-Wellcome Trust 24 
2 
Collaborative Research Programme, Kilifi, Kenya. Tanya Golubchik: Wellcome Trust 25 
Centre for Human Genetics, University of Oxford, UK. 26 
 27 
Length: 2999 words (limit 3000 excluding Materials and Methods), 3 Tables (plus 4 28 
Supplementary), 3 Figures (plus 2 Supplementary)  29 
3 
Abstract (249 words, limit 250 words) 30 
Background: In principle, whole genome sequencing (WGS) can predict phenotypic 31 
resistance directly from genotype, replacing laboratory-based tests. However, the 32 
contribution of different bioinformatics methods to genotype-phenotype discrepancies 33 
has not been systematically explored to date. 34 
Methods: We compared three WGS-based bioinformatics methods (Genefinder (read-35 
based), Mykrobe (de Bruijn graph-based) and Typewriter (BLAST-based)) for predicting 36 
presence/absence of 83 different resistance determinants and virulence genes, and 37 
overall antimicrobial susceptibility, in 1379 Staphylococcus aureus isolates previously 38 
characterised by standard laboratory methods (disc diffusion, broth and/or agar 39 
dilution and PCR). 40 
Results: 99.5% (113830/114457) of individual resistance-determinant/virulence gene 41 
predictions were identical between all three methods, with only 627 (0.5%) discordant 42 
predictions, demonstrating high overall agreement (Fliess-Kappa=0.98, p<0.0001). 43 
Discrepancies when identified were in only one of the three methods for all genes except 44 
the cassette recombinase, ccrC(b). Genotypic antimicrobial susceptibility prediction 45 
matched laboratory phenotype in 98.3% (14224/14464) cases (2720 (18.8%) resistant, 46 
11504 (79.5%) susceptible). There was greater disagreement between the laboratory 47 
phenotypes and the combined genotypic predictions (97 (0.7%) phenotypically-48 
susceptible but all bioinformatic methods reported resistance; 89 (0.6%) 49 
phenotypically-resistant, but all bioinformatics methods reported susceptible) than 50 
within the three bioinformatics methods (54 (0.4%) cases, 16 phenotypically-resistant, 51 
38 phenotypically-susceptible). However, in 36/54 (67%), the consensus genotype 52 
matched the laboratory phenotype.  53 
4 
Conclusions: In this study, the choice between these three specific bioinformatic 54 
methods to identify resistance-determinants or other genes in S. aureus did not prove 55 
critical, with all demonstrating high concordance with each other and 56 
phenotypic/molecular methods. However, each has some limitations and therefore 57 
consensus methods provide some assurance. 58 
  59 
5 
Introduction 60 
Staphylococcus aureus causes both superficial infections (such as boils) and life-61 
threatening disease including septicaemia (1). There were 11,405 S. aureus 62 
bacteraemias in England in 2015/2016 (2); 7.2% were meticillin resistant S. aureus 63 
(MRSA) which has increased costs and poorer patient outcomes (3). Fast accurate 64 
resistance prediction is key to managing S. aureus infections. Molecular-based methods 65 
directed at detecting specific genes, e.g. through rapid multiplex PCR and microarrays, 66 
can reduce time to identify resistance determinants and time on broad-spectrum 67 
antibiotics (4-6). However, they require specific primers that impact sensitivity and 68 
specificity. 69 
  70 
 In principle, whole genome sequencing (WGS) has the potential to predict phenotypic 71 
resistance directly from genotype, replacing laboratory-based phenotypic tests (7). 72 
Several studies report high concordance between genotypic predictions based on known 73 
or novel resistant determinants and phenotypic methods (8-13). However, these studies 74 
used varying sequence processing pipelines and bioinformatics methods to identify in 75 
silico resistance determinants. Without formal comparisons between the various 76 
methods, it is unclear whether the underlying differences affect results, or whether 77 
differences in methodology could cause some of the observed discrepancies between 78 
genotypic predictions and phenotype.  79 
  80 
Here, we therefore compare three WGS-based bioinformatics methods (Genefinder 81 
(read-based), Mykrobe (de Bruijn graph-based) and Typewriter (BLAST-based)) in 82 
terms of predictions of presence/absence of different resistance determinants, and 83 
6 
overall prediction of antimicrobial susceptibility and presence/absence of virulence 84 
genes, from short-read Illumina WGS. 85 
 86 
Results 87 
Short-read Illumina WGS were available from 1,389 samples, 992 from a collection held 88 
in Oxford (previously described by Gordon et al (9, 10)) and 397 from Public Health 89 
England (PHE) Staphylococcus Reference Service, Colindale. Ten samples were excluded 90 
due to mixed/contaminated WGS results, leaving 1,379 for analysis. Samples were 91 
analysed by Genefinder and Typewriter (Table 1) after sequence mapping and variant 92 
calling and by Mykrobe from raw fastq reads.  93 
 94 
84 genes were included: 46 acquired resistance genes, five sets of chromosomal variants 95 
within genes associated with resistance, three cassette chromosome recombinases ccrA, 96 
ccrB and ccrC including three variants of ccrC (ccrCa, ccrCb, ccrCc) and 28 virulence 97 
genes (Supplementary Table 1). 99.5% (113830/114457) of the individual resistance-98 
determinant/virulence gene predictions were identical between all three methods 99 
(Supplementary Table 1, Figure 1), with only 627 (0.5%) discordant predictions, 100 
demonstrating high overall agreement (Fliess-Kappa=0.98, p<0.0001). Overall, one 101 
method disagreed with both other methods in 0.23% for Typewriter (263/114457 102 
predictions), 0.16% Mykrobe (183/114457) and 0.16% Genefinder (181/114457). The 103 
three most common discrepancies for Typewriter were the non-detection of virulence 104 
genes identified by other methods (seu 57 samples, chp 46 samples, sei 33 samples). 105 
Similarly, for Genefinder the three most common discrepancies were non-detection of 106 
resistance genes (qacB 44 samples, dfrC 34 samples) or other genes (ccBb 22 samples) 107 
identified by other methods. Genefinder reported the presence of dfrA, qacA or ccrC(b) 108 
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genes in these samples. In contrast, Typewriter and Mykrobe reported the presence of 109 
two dfr, two qac and three ccrC genes, where the detected variants for each of these 110 
three genes shared more than 90% nucleotide identity. The most common discrepancies 111 
for Mykrobe were identifying resistance/other genes as present when the other two 112 
methods called them absent (aadE/ant(6)-Ia 28 samples, blaZ 19 samples, ccrCB 22 113 
samples). No gene was ever identified as present by Typewriter alone. 14 of the 84 114 
genes had >1% discrepancies (maximum 4.3% for seu), but the majority of discrepancies 115 
were in only one method for all genes except ccrC(b).  116 
 117 
Discrepancies were similar in acquired resistance genes (0.3%, 221/63434) and 118 
chromosomal resistance genes (0.1%, 8/5516), but slightly larger for ccr genes (1.8%, 119 
123/6895) and virulence genes (0.7%, 275/38612) (Supplementary Table 2). 120 
Percentage discrepancies varied modestly across the different sample sets, being higher 121 
for the PHE set (1.1%, 349/32,928; particularly for ccr genes with 4.2% (83/1,960) 122 
discrepancies), intermediate for the Oxford derivation set (0.6%, 233/42084) and 123 
lowest for the Oxford validation set (0.1%, 45/40,824) (Supplementary Table 2). 124 
 125 
Genotypic predictions of antimicrobial susceptibility were also identical in 99.6% of 126 
cases (16,477/16,548 predictions, Table 2). Of the 71 discrepancies in susceptibility 127 
prediction between the methods, 42% (30/71) occurred with Typewriter reporting 128 
susceptible when Genefinder and Mykrobe reported resistant, and 49% (35/71) 129 
occurred with Mykrobe reporting resistant where Genefinder and Typewriter reported 130 
susceptible.  131 
 132 
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Comparing genetic predictions to laboratory phenotypes (restricted to samples either 133 
phenotypically resistant or susceptible), in 98.3% (14224/14464) cases all three 134 
bioinformatics methods and the gold standard laboratory results agreed completely 135 
(2720 (18.8%) resistant, 11504 (79.5%) susceptible) (Table 3a, Figure 2). There was 136 
greater disagreement between the laboratory phenotypic results and the combined 137 
genotypic predictions than within the three bioinformatics methods. In 97 (0.7%) 138 
instances, the laboratory phenotype was susceptible but all bioinformatic methods 139 
reported resistance. Of these, 33% (32/97) were for penicillin, 23% (22/97) 140 
clindamycin and 11% (11/97) erythromycin, with smaller numbers for fusidic acid (7), 141 
tetracycline (6), mupirocin (6), methicillin (5), ciprofloxacin (4), gentamicin (3) and 142 
rifampicin (1), and none for trimethoprim. In 89 (0.6%) instances, the laboratory 143 
phenotype was resistant, but all three bioinformatics methods reported susceptible, 144 
most commonly to gentamicin (21%, 15/89), ciprofloxacin (17%, 15/89) and fusidic 145 
acid (15%, 13/89). The remaining 54 (0.4%) cases (16 phenotypically-resistant, 38 146 
phenotypically-susceptible) had different genotypic predictions made from the different 147 
methods. However, in 36/54 (67%), the consensus genotype (predicted by two of the 148 
three methods) matched the laboratory phenotype.  149 
 150 
PCR/array results were available for some virulence genes (14) and mecA/mecC for all 151 
397 PHE isolates. Compared with genetic predictions, in 96.8% (3983/4115) cases all 152 
three bioinformatics methods and the PCR/array results agreed completely (3364 153 
(81.7%) absent, 619 (15.0%) present) (Table 3b, Supplementary Figure 1). As for 154 
antimicrobial resistance, there was greater disagreement between the laboratory 155 
PCR/array results and the combined genotypic predictions than within the three 156 
bioinformatics methods, with 81 (2.0%) cases where all three methods called a gene 157 
9 
present that had not been detected by PCR/array and 12 (0.3%) where no method called 158 
a gene present that had been detected by PCR/array, in comparison with 39 (0.9%) 159 
discrepant predictions between the methods. In 20/39 (51%), the consensus genotype 160 
matched the PCR/array result. 161 
 162 
The sensitivity and specificity of all three bioinformatics methods compared to 163 
laboratory phenotypic methods in predicting antimicrobial susceptibility was very 164 
similar. Across the 14464 genotypic predictions, Typewriter had the lowest overall 165 
sensitivity (0.964 (95% CI 0.956-0.970), but the highest specificity (0.992 (0.990-166 
0.993)), while Mykrobe had higher sensitivity (0.967 (0.960-0.974)) and lowest 167 
specificity (0.989 (0.987-0.990)). Genefinder’s performance fell between Mykrobe and 168 
Typewriter for specificity (0.990 (0.988-0.992)) with a sensitivity equal to Mykrobe 169 
(0.967 (0.960-0.973)). Specificity and sensitivity varied across the different antibiotics 170 
(Figure 3), but were broadly similar between the three methods, overall and within each 171 
dataset (Supplementary Table 3). There were no vancomycin resistant isolates 172 
identified by either phenotyping or bioinformatics methods. Similarly, specificity and 173 
sensitivity to identify PCR-detected virulence and other genes varied across the different 174 
genes, but were broadly similar between the three methods (Supplementary Figure 2).  175 
 176 
Discussion 177 
Whilst WGS is increasingly used to detect antibiotic resistance and virulence 178 
determinants, to our knowledge this is the first study that compares three methods for 179 
predicting genotype on large numbers of isolates. As discussed in the recent European 180 
Committee on Antimicrobial Susceptibility Testing (EUCAST) report (15), discordance 181 
can occur between phenotypic and genotypic resistance due to inadequate limits of 182 
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detection for WGS methods, incomplete understanding of the genotypic basis of 183 
phenotypic resistance, flaws with the phenotypic or molecular (e.g. PCR) methods 184 
currently used to detect resistance, and/or WGS failures including lack of assembly 185 
caused by multiple operons or similar sequences, incomplete gene coverage, non-186 
functional genes (e.g., due to presence of stop codons/indels) or cropped contigs.  187 
 188 
Here we found that three different approaches to identifying genetic determinants of 189 
resistance and virulence (Genefinder, Mykrobe and Typewriter) agreed in 99.5% 190 
predictions. Genefinder and Mykrobe were fast, taking under five minutes whereas 191 
Typewriter, while also taking a few minutes per sample, required initial genome 192 
assembly that increased turnaround time by up to three hours. Mykrobe and Typewriter 193 
are freely available (https://github.com/iqbal-lab/Mykrobe-predictor and 194 
https://github.com/tgolubch/typewriter respectively); Genefinder is not but the 195 
underpinning methods are relatively straightforward, and the freely available SRST2 196 
(https://github.com/katholt/srst2) follows an analogous mapping approach (16) which 197 
would likely provide very similar results with the same catalogue. Previous comparisons 198 
of bioinformatics methods relevant to the microbiology community are limited. Bradley 199 
et al (9) found good concordance between Mykrobe and SeqSphere (17), an allele-based 200 
method that detects presence/absence of a limited number of resistance and virulence 201 
markers. SeqSphere took longer than Mykrobe as, like Typewriter, it uses Velvet 202 
assemblies. Other previous studies have shown 100% concordance between resistome 203 
and toxome in 14 MRSA isolates (18), 98.6% concordance across 5288 susceptibility 204 
predictions in 308 S. aureus isolates (both MRSA and MSSA) (19), 100% concordance for 205 
selected resistance and toxin gene presence/absence in 18 MRSA strains (17), and 206 
97%/97% sensitivity/specificity for Typewriter and 99.1%/99.6% 207 
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sensitivity/specificity for Mykrobe for predicting phenotypic resistance in the Oxford 208 
validation samples used here (9, 10). A comparison between microarray and WGS in 154 209 
isolates reported 1.7% discordancy in detecting resistance and virulence genes (20), 210 
mainly due to failure of WGS to detect enterotoxins and super antigens (similar to 211 
Typewriter in this study).  212 
 213 
Individually, the three programs demonstrated high concordance, but interestingly, in 214 
almost all genes only one of the three bioinformatics methods did not identify a 215 
determinant that the other two methods did identify, or vice versa. The most common 216 
discrepancy with Typewriter was failing to identify virulence genes identified by 217 
Mykrobe and Genefinder (namely, seu, chp and sei). Two of these genes, sei and seu, are 218 
located on the enterotoxin gene cluster (egc) (21, 22), referred to as an enterotoxin gene 219 
nursery (23), and the other, chp, on a prophage (24). Such regions may be particularly 220 
susceptible to recombination (25, 26) and paralogs. As Typewriter uses BLAST, it may 221 
have a higher chance of detecting one of multiple closely related genes than the other 222 
two methods.  223 
 224 
Similarly to Typewriter, the most common discrepancy with Genefinder was failing to 225 
identify genes reported by Typewriter or Mykrobe, particularly ccrB, qacB (quaternary 226 
ammonium compound B, conferring resistance to chlorexidine (27) via an efflux drug 227 
pump, but differing from another gene, qacA, by only seven nucleotides (28)), and dfrC 228 
(a dihydrofolate conferring resistance to trimethoprim believed to be the origin of the 229 
more common transposon-associated drfA gene). The fact that Genefinder identified 230 
only one variant of acquired dfr and qac may indicate that the other two methods were 231 
misidentifying paralogs (29). Alternatively, as Genefinder detects pre-determined 232 
12 
alleles, recombination of partial genes or differences in flanking sites or genomic 233 
variation alone may reduce its ability to detect some genes. One advantage of Genefinder 234 
is its ability to detect variations in multicopy genes such as the ribosomal RNA encoding 235 
genes associated with linezolid resistance in staphylococci. 236 
 237 
In contrast, Mykrobe most commonly identified a determinant that other methods did 238 
not, particularly aadE(ant6’)-Ia, an adenyltransferase encoding resistance to 239 
aminoglycosides. This gene is associated with small plasmids flanked by direct repeats 240 
of staphylococcal insertion sequence IS257 (30). Although Mykrobe is kmer-based, it 241 
requires a high match across the whole gene, not just flanking sequences, so the reason 242 
for this is unclear. Mykrobe also had a higher false-positive rate in blaZ, as reported 243 
previously (9). Although this was previously attributed to phenotypic errors, the fact 244 
that neither Genefinder nor Typewriter identified blaZ in these isolates suggests the 245 
algorithm/threshold may need adjusting for this gene. Mykrobe also had a high false-246 
positive rate for the ccrCB gene, which is part of the cassette chromosome recombinase 247 
(ccr) associated with SSCmec (31). As all ccrC genes share >87% similarity, and were not 248 
included in the original Mykrobe implementation, further investigation and modification 249 
of sequence identity thresholds may be required to accurately classify this gene, whose 250 
different alleles can have 60-82% sequence identity.  251 
 252 
Overall, the comparison highlights key challenges inherent in all methods. First is the 253 
trade-off between specificity and sensitivity to detect specific genes/variants, and the 254 
need for adjustment based on specific features, such as proximity to repetitive elements 255 
or similarity with other alleles. Specific genes may also require different approaches, e.g. 256 
the ccr genes were the most discordant overall in the study. These genes were more 257 
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often present in the Staphylococcal reference laboratory isolates, increasing overall 258 
error rates for this sample set. Reference libraries of genes/variants also require 259 
frequent updating with new alleles, and appropriate thresholds must be set to allow 260 
separate copies of closely related genes (e.g. qacA and qacB) to be detected if genuinely 261 
present. Taking the consensus prediction across the three different bioinformatics 262 
methods is one strategy for balancing these different trade-offs. As error rates were low 263 
overall, this only improved genetic predictions slightly, but in samples where the 264 
susceptibility is unknown it could be valuable, particularly if the two fast 265 
implementations (GeneFinder, Mykrobe) are used, followed by the slower assembly-266 
based method only if they disagree. 267 
 268 
Our main findings were that the largest discordance occurred between phenotype and 269 
genotype regardless of the method used to predict genotype, and that the “consensus” 270 
genotypic prediction agreed with the phenotype in two-thirds of the small number of 271 
cases where bioinformatics methods made different predictions. Where bioinformatics 272 
methods are concordant, but disagree with phenotype, the unresolved question is which 273 
is “correct”, in terms of a drug achieving clinical cure in a patient infected with this 274 
strain. Penicillin and clindamycin/erythromycin were most likely to be called resistant 275 
by all methods but susceptible by phenotyping. Previous studies of erythromycin and 276 
clindamycin resistance have reported positive ermC PCR results from non-detectable 277 
resistance phenotypes (32) and have suggested that plasmids conferring resistance to 278 
these antibiotics may be lost in subculture (9, 33). Sensitivity to penicillin by phenotypic 279 
methods where genotype methods predict resistance has been reported previously (34, 280 
35) and the evidence suggests that phenotyping underreports resistance. The EUCAST 281 
guidelines illustrate the challenges in distinguishing between penicillin-resistant and -282 
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susceptible isolates based on fuzzy versus sharp zones (36). Overall therefore it is 283 
plausible that genetic detection of resistance may reflect more closely the impact of the 284 
strain on a patient. 285 
 286 
Interpretation where phenotyping reports resistance but WGS methods predict 287 
susceptibility is more difficult. One possibility is small colony variants (SCV) being 288 
present phenotypically but overgrown in WGS culture and thus not represented in the 289 
sequence. Resistance associated with gentamicin, fusidic acid and ciprofloxin, the main 290 
antibiotics where this phenomenon was observed, is observed with SCV phenotypes (37, 291 
38). An alternative explanation is novel resistance mechanisms, for example, 292 
ciprofloxacin (39), leading to false-negative WGS predictions. The need for a 293 
continuously updated curated database is a key challenge for WGS methods. As more 294 
sequencing occurs, novel mutations will be identified in resistance genes that may or 295 
may not confer phenotypic resistance, but these can at least be identified and tested;  296 
identifying entirely new resistance-conferring genes is more complex and prediction 297 
software that can recognize new, clinically important genes a priori would be a valuable 298 
addition to an analysis pipeline. However, we observed similar differences between 299 
concordant genotypic predictions and both phenotypic antimicrobial susceptibilities 300 
and single gene PCR results, suggesting that the underlying causes may not necessarily 301 
be related to resistance. As previously noted, agreement between WGS and phenotyping 302 
is higher (98.6%) than between phenotyping undertaken by two separate laboratories 303 
(97.6%) (19), thus at least some discrepancies are probably due to incorrect 304 
phenotyping results. In contrast, concordance between genotypic predictions made 305 
using a single method but based on WGS generated from 5 different laboratories was 306 
recently shown to be >99.8% (40). 307 
15 
Limitations 308 
This comparison was based on a pre-specified set of resistance or virulence associated 309 
genes: some genetic traits previously associated with resistance were omitted (eg. IleS 310 
mutations linked to low-level mupirocin resistance). Despite this, we found good 311 
agreement between genotypic predictions and phenotype. Typewriter used Velvet de 312 
novo assemblies: other newer assemblers (e.g. SPADES (41)) might have improved 313 
predictions further. We included data which had been used in development of two of the 314 
methods compared, which could potentially have led to over-fitting, although 315 
performance of all three methods was in fact similar on this dataset (Supplementary 316 
Table 3). All analysis was undertaken on short-read Illumina data. The increasing use of 317 
long-read sequences will require further software testing, although Mykrobe has been 318 
successfully used for initial resistance calling in Mycobacterium tuberculosis from 319 
Nanopore sequencing in a small number of samples (42). However, it has not been 320 
comprehensively tested, nor have Typewriter or Genefinder, with long-read sequences 321 
generated using Nanopore or PacBio technology. The greatest differences detected in 322 
this study were between phenotype and genotype, which could be partly due to the 323 
method of phenotypic testing and recognised issues with reproducibility. We did not 324 
have resources to re-phenotype all or a subset of the isolates; well-characterised sets of 325 
repeatedly phenotyped isolates would be useful for further studies. We found no 326 
suggestion that missing calls in one program were associated with scores just below a 327 
threshold, but did not undertake a more detailed assessment of specific sequence 328 




In summary, in this study the choice between three specific bioinformatic methods to 332 
identify resistance-determinants or other genes in S. aureus did not prove critical. All 333 
demonstrated a high concordance with each other, and phenotypic methods, and can be 334 
recommended for genotype prediction. However, each has some limitations and 335 
therefore consensus methods provide at least some assurance. Due to computational 336 
speed, Mykrobe (de Bruijn graph-based) and Genefinder (or equivalent mapping-based 337 
program such as SRST2 (16)) are a sensible combination to use as an initial consensus 338 
method, followed by Typewriter (BLAST-based) if these two methods disagree. As a set 339 
of 34 diverse bacteria have been made available for whole genome sequencing 340 
validation (43), the study strains and genotypic predictions are available as a resource 341 
for other studies investigating different bioinformatic analysis methods which will 342 
become increasingly important as this technique is more widely used to inform clinical 343 
management, though bacterial identification, antimicrobial susceptibility prediction and 344 
virulence profiling. External quality control of clinical laboratory performance in 345 
predicting antibiotic resistance is provided by UK proficiency testing schemes such as 346 
UK NEQAS (United Kingdom National External Quality Assessment Service for 347 
Microbiology) (44); a similar set of standards will need to be created to accredit whole 348 
genome sequencing methods. 349 
 350 
Materials and Methods 351 
Three sets of S. aureus isolates with known high-quality phenotypes were analysed: a 352 
derivation, n=501, and validation, n=491, set (denoted “Oxford derivation/validation”) 353 
from blood cultures and nasal swabs isolates at the Oxford Radcliffe Hospitals NHS Trust 354 
and Brighton and Sussex University Hospitals NHS Trust, spanning a period of 13 years, 355 
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sequenced for an initial assessment of genotypic prediction of susceptibility phenotype 356 
in S. aureus (9, 10)and 397 isolates that had been referred to the Public Health England 357 
reference laboratory for investigation (denoted “Colindale 397”, available at NCBI: 358 
PRJNA445516). The Oxford derivation set had previously been used in the development 359 
of Typewriter and Mykrobe, but not Genefinder; the former methods were then applied 360 
to the Oxford validation set.  361 
 362 
Phenotypes for “Oxford derivation/validation” isolates used disc diffusion and/or 363 
automated broth diffusion (BD Phoenix) with discrepancies between phenotype and 364 
genotype resolved as described previously (11). All PHE isolates (n=397) were 365 
subjected to MIC testing by the PHE Staphylococcal Reference Laboratory using the agar 366 
dilution method (45). In addition, the mecA/C status and virulence gene profile of the 367 
PHE isolates was determined by PCR or microarray testing as described previously (14). 368 
The European Committee on Antimicrobial Susceptibility Testing (EUCAST): thresholds 369 
were used to determine sensitivity or resistances for each phenotype 370 
(http://www.eucast.org/clinical_breakpoints). 371 
 372 
All “Oxford derivation/validation” isolates were sequenced using the Illumina HiSeq 373 
2000 platform as previously described (46). PHE samples were sequenced in an 374 
Illumina HiSeq 2500 platform as described previously (47) (both 150bp reads). Samples 375 
determined as mixed based on WGS were excluded from further analysis. Quality control 376 
of sequences at PHE used the trimmomatic software (Illumina adapter removed, leading 377 
and trailing quality threshold set to 30 and minimum length of read set to 50 bases) 378 
(48).  Isolates from Oxford analysed by Typewriter were mapped and de novo 379 
assembled with exclusion parameters of <70% coverage of reference genome for 380 
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mapping and <50% of the genome in contigs >1 Kb (10). Mykrobe processes raw 381 
sequence data with no prior cleaning of the data. Isolates came from 111 sequence 382 
types, including 29 new STs/alleles, covering the range of S. aureus genomic diversity as 383 
previously described in Oxfordshire.  384 
 385 
Three programs, Genefinder (MD; PHE, not published), Mykrobe (PB; Version v0.3.13-2-386 
gd5880fa, open-source at https://github.com/iqbal-lab/Mykrobe-predictor), and 387 
Typewriter (TG; version 2.0, MMM group, Oxford University, 388 
https://github.com/tgolubch/typewriter) (Table 1), were compared to determine 389 
presence/absence of resistance-determinants (genes or variants) and toxin genes 390 
(Tables 2, 3). Mykrobe is part of the automated processing with the Complete Pathogen 391 
Software Solution (COMPASS) developed at University of Oxford. This returns quality 392 
and depth of sequence metrics, maps against a reference (MRSA 252, GenBank 393 
Accession no: BX57186561) using Stampy (49) and performs de novo assembly using 394 
Velvet v1.0.18 (50). These de novo assemblies formed the basis for the Typewriter 395 
program, whereas Genefinder used the raw sequencing reads. 396 
 397 
Although all three methods search for matches to a pre-defined list of alleles, they have 398 
different approaches to their identification (further details below). Genefinder and 399 
Mykrobe required fastq files whereas Typewriter used BLAST on de novo assemblies. All 400 
used pre-set thresholds to detect genes. Thresholds are adapted for certain genes (e.g. 401 
blaZ which can be chromosomally integrated or carried on plasmids) to improve 402 
prediction and for quality control. Both Typewriter and Mykrobe identified presence or 403 
absence of each target singly, whereas Genefinder identified which of closely related 404 
homologs is most plausibly present. Genefinder and Mykrobe were very fast, between 405 
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one and three minutes, and can be used on a standard desktop computer (specification 406 
of 2.3 GHz processor and 16GB memory). Typewriter, as it requires de novo assembly, 407 
took up to three hours and used cloud computing or high-capacity servers.  408 
 409 
Genefinder was written by MD. It used a mapping approach (similar to SRST2, 410 
https://github.com/katholt/srst2) to detect the presence or absence of predefined 411 
genes or variations in predefined genes using Bowtie. Thresholds were defined at 90% 412 
overall, but amended where required in order to distinguish between both variants 413 
where genes were represented with multiple reference sequences and the level of 414 
diversity expected for each gene sought. Genefinder also checked for premature stop 415 
codons and compared the average depth of read coverage to identify any potential 416 
sequence contamination. 417 
 418 
Mykrobe was written by PB and ZI (9). A threshold frequency was generated for each 419 
gene (K minimum percentage) based on the empirical level of diversity observed in the 420 
training set described by Bradley (K=0.3 for blaZ, K=0.6 for fusB, fusC, K=0.8 otherwise). 421 
The maximum likelihood from 3 models (gene absent, gene present in minor proportion, 422 
gene present) was chosen. The models took into account expected proportion of kmers 423 
based on depth of coverage and empirical level of diversity (described in (9)). Mutations 424 
were genotyped by choosing the maximum likelihood model from 3 Poisson models 425 
comparing the depth of coverage across 63 base pair reference and alternate alleles 426 
while demanding 100% coverage across the allele, also described in (9). 427 
 428 
Typewriter was developed by TG (described in (10)). It considered BLAST results over a 429 
query reference (blastn for sequence identity, tblastn for mutations). It used a “relative 430 
20 
coverage” to determine presence/absence of a gene, a metric that gives equal weight to 431 
coverage and sequence identity. Typewriter reported this value for each query gene of 432 
interest and cutoffs were adjusted to optimize specificity/sensitivity for different genes. 433 
In this study, a relative cutoff of 90% for resistance and toxin genes was used except 434 
blaZ for which a cutoff of 80% was used. For variant reporting, mutations were reported 435 
above a given threshold of relative coverage (e.g. 90%) however, this could be changed 436 
or set to 0% to report all identified differences from the query sequence. Stop codons 437 
were predicted, as were novel mutations. 438 
 439 
84 genes were included in the analysis; 46 acquired resistance genes, five sets of 440 
chromosomal variants within resistance-associated genes, five cassette chromosome 441 
recombinases (ccr) and 28 virulence genes (Tables 2, 3). Acquired resistance genes were 442 
classified as present (p,P) or absent (a, A), setting 3 missing Genefinder predictions 443 
(“ND” or “X”) to absent. Chromosomal resistance variants were those listed in 444 
Supplementary Table 4; 23 other mutations were reported in the relevant genes but 445 
were not compared, as they are not considered resistance-determinants 446 
(Supplementary Table 4). For all methods, genotype predictions of susceptibility 447 
phenotype were based on the presence of any relevant resistance-determinant as shown 448 
in Tables 2 and 3 (as described in (10) with minor modifications and updates from (9)). 449 
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Figure legends 646 
Figure 1: Determinant-by-determinant disagreements between methods  647 
Each panel shows percentage difference in proportion of detected presence of each 648 
determinant between the first method and the second. 649 
 650 
Figure2: Antimicrobial susceptibility genotypic predictions compared to phenotype 651 
 652 
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Table 1 Overview of Genefinder, Mykrobe and Typewriter methods and 668 
requirements  669 
 Genefinder MyKrobe (9) Typewriter (10) 
Method Maps raw reads to 
list of target alleles 
using Bowtie 
Looks for list of target 
alleles in de Bruijn 
assembly graph 
Blasts list of target 
alleles against de 
novo assemblies*  






>90% to target 
allele 
Based on Kmer 
recovery: K is 
minimum percentage 
expected to be 
recovered for a gene; 
K = 0.3 for blaZ, K=0.6 









>90% to target: 
can be modified  
100% of 63 kmers 
required to call a 
variant present 
 >90% to target: can 
be modified  
Prediction of stop 
codons in genes 
present 
Yes No: there is no 
assembly  
Yes 
Reads can be 
mapped to 
Multiple targets Single target Single target 
32 
 Genefinder MyKrobe (9) Typewriter (10) 
Speed / processor 1 to 3 minutes on 
laptop with 2.3 
GHz processor and 
16GB memory† 
2 minutes on laptop 
with 2.3 GHz 
processor and 16GB 
memory 
3 hours for 
assemblies on cloud 
computational 
system, then few 




if gene has multiple 
reference sequence 





depth of coverage 
Can identify mixtures 
of difference species 
and same species  




reported if below 
these thresholds 
 670 
* using blastn for sequence identity and tblast for mutations.  671 
  672 




Table 2: Predicted antibiotic susceptibility phenotype from WGS by Genefinder, 676 
Mykrobe, Typewriter (n=1379) 677 
Antibiotic 






RRR SSS RRS RSR RSS SRS  
Ciprofloxacin 304 1072 0 2 0 1 3 (0.2%) 
Clindamycin 338 1024 7 0 0 10 17 (1.2%) 
Erythromycin 354 1011 6 0 0 8 14 (1.2%) 
Fusidic acid 151 1221 4 0 0 3 7 (0.5%) 
Gentamicin 76 1300 1 0 0 2 3 (0.2%) 
Methicillin 393 984 2 0 0 0 2 (0.1%) 
Mupirocin 15 1362 0 0 2 0 2 (0.1%) 
Penicillin 1,161 211 3 0 0 4 7 (0.5%) 
Rifampicin 23 1,354 0 1 0 1 2 (0.1%) 
Tetracycline 121 1,249 4 0 0 5 9 (0.7%) 
Trimethoprim 175 1,199 3 1 0 1 5 (0.4%) 
Vancomycin 0 1,379 0 0 0 0 0 (0.0%) 


















  680 
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Table 3: Predicted genotype and phenotype  681 
(a) Antimicrobial susceptibility 682 
 
Antimicrobial susceptibility prediction from Genefinder, 




RRR SSS RRS RSR RSS SRS Total 
R 2720 89 9 3 0 4 2825 
S 97 11504 13 1 2 22 11639 
Total 2817 11593 22 4 2 26 14464 
 683 
(b) Virulence genes, ccr genes and mecA/mecC 684 
 
Prediction from Genefinder, Mykrobe, 
Typewriter  
 
PCR AAA PPP APA PPA Total 
A 3362 82 10 17 3475 
P 14 618 2 10 643 
Total 3376 700 12 27 4115 
 685 
Note: not all isolates were phenotyped for all antimicrobials, and therefore total with 686 
phenotypes (14464) is less than the total with genotypic predictions (16548) in Table 2. 687 
Only PHE isolates had PCR results for some virulence genes. Dark grey shading shows 688 
complete concordance, and light grey majority concordance between predictions. 689 
R=resistant, S=susceptible, A=absent, P=present690 
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